Overview

Tech Summary

Promoter Holding

Posts

ZYDUSWELL

10123456789,501234567896012345678970123456789.4012345678950123456789
+2.45 (+0.16%)
The current prices are delayed.Login/Sign Upto see live prices.
Previous Close: 1565
1D
5D
1M
3M
1Y
5Y
MAX
Today's low
1558
Today's high
1575.7
52 week low
1370.1
52 week high
1791
Volume
14751
About
TECHNICAL SUMMARY
DMA(12)
₹1584.69
DMA(50)
₹1660.86
DMA(100)
₹1639.3
DMA(200)
₹1603.57
FUNDEMANTAL SUMMARY
Market Cap
₹9968.98 Cr.
Enterprise Value
₹10223.3 Cr.
No. of Shares
6.36
P/E
35.15
RoE
6.23
Debt/Equity
0.06
Valuations
PE CHART
140160180200220
PB CHART
1.701.801.902.002.10
Promoter Holdings
Public : 7.62%
FII : 3.23%
DII : 22.05%
Promoter : 67.1%
Others : 0%
Charts
DEBT/EQUITY
0.100.200.300.40
Mar, 2019Mar, 2020Mar, 2021Mar, 2022Mar, 2023
ROE VS ROCE
3.04.05.06.07.08.09.0
Mar, 2019Mar, 2020Mar, 2021Mar, 2022Mar, 2023
ROE
ROCE
REVENUE VS PROFITABILITY (1000CR.)
0.51.01.52.0
Mar, 2019Mar, 2020Mar, 2021Mar, 2022Mar, 2023
Revenue
Profit
MARGINS(%)
10152025
Mar, 2019Mar, 2020Mar, 2021Mar, 2022Mar, 2023
Net Margin
Gross Margin
Posts by FrontPage Users
NewsBot-display-image
Reputation: 171,463  •  Aug 11 7:21 PM
Zydus Lifesciences Q1 Results: Profit more than doubles on US sales growth
Zydus Lifesciences Q1 Results: Profit more than doubles on US sales growth
Its U.S formulations business saw a revenue growth of 57.4% to 24.54 billion rupees, while India formulations grew by 9.1% to 12.27 billion rupees. India and U.S. sales make up 38% and 48% of Zydus' total revenue, respectively.
The Economic Times
Upvote
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 171,463  •  Aug 9 10:41 PM
Technical breakout: SBI, Zydus Wellness, 5 other stocks cross 100-day SMA
Technical breakout: SBI, Zydus Wellness, 5 other stocks cross 100-day SMA
August 08, 2023, witnessed a dynamic shift in the stock market as several prominent stocks demonstrated impressive market performance by crossing their 100 Simple Moving Averages (100 SMA).
The Economic Times
Upvote
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 171,463  •  Aug 8 11:56 AM
Another Jhunjhunwala long bet blooms with Concord Biotech offer
Another Jhunjhunwala long bet blooms with Concord Biotech offer
The ace investor often called India's Warren Buffet, first invested in Concord in 2004 and later helped the company's founder in buying back the company from pharma major Mylan in 2009.
The Economic Times
Upvote
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 171,463  •  Aug 8 4:23 AM
Bulk deals | Plutus Wealth Management buys additional 1.16% stake in Yatharth Hospital
Bulk deals | Plutus Wealth Management buys additional 1.16% stake in Yatharth Hospital
Plutus held 2.33 percent stake in Yatharth Hospital as per the shareholding data disclosed by the company last week.
Moneycontrol
Upvote
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 171,463  •  Aug 7 3:58 PM
Buy Zydus Wellness; target of Rs 1654: Sharekhan
Buy Zydus Wellness; target of Rs 1654: Sharekhan
Sharekhan is bullish on Zydus Wellness has recommended buy rating on the stock with a target price of Rs 1654 in its research report dated August 03, 2023.
Moneycontrol
Upvote
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 171,463  •  Aug 7 3:46 PM
Stocks to buy today: Lupin, ONGC among top 9 trading ideas for 7 August 2023
Stocks to buy today: Lupin, ONGC among top 9 trading ideas for 7 August 2023
On the weekly front, the maximum Call OI is placed at 19600 and then towards 19,700 strikes while the maximum Put OI is placed at 19,400 and then towards 19,500 strikes.
The Economic Times
1 Upvote
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 171,463  •  Aug 3 9:06 PM
Zydus Lifesciences gets USFDA nod for generic rheumatoid arthritis treatment drug
Zydus Lifesciences gets USFDA nod for generic rheumatoid arthritis treatment drug
Zydus Lifesciences has gained the US Food and Drug Administration's (FDA) approval to produce and market its Indomethacin suppositories. The drug is used to treat moderate to severe rheumatoid arthritis and acute flares of chronic disease, among other conditions. Zydus has been awarded 180-day CGT exclusivity to market the product after US authorities deemed there was a lack of competition.
The Economic Times
Upvote
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 171,463  •  Aug 2 9:56 PM
HCL Tech, Nykaa and 8 other counters cross 20-day SMA
HCL Tech, Nykaa and 8 other counters cross 20-day SMA
The stock market witnessed notable movements as several stocks surged above their 20-day Simple Moving Average (SMA) on 1st August 2023, indicating bullish momentum. Investors are closely observing these stocks for potential investment opportunities in the market
The Economic Times
Upvote
Comment
Share
Add a comment
Bhaskar Raul-display-image
Reputation: 16  •  Aug 2 3:22 PM

#ZYDUSWELL LOOKING GOOD FOR INVESTMENT
LOOK AT THE CHART FOR ENTRY AND TARGET
Chartbusters - chart - 119476518
Upvote
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 171,463  •  Jul 28 9:51 PM
Stocks on the rise! DLF, Marico and more cross 50-day SMA
Stocks on the rise! DLF, Marico and more cross 50-day SMA
5 counters crossed their 50-day Simple Moving Average (SMA) on July 27, 2023. Marico and Zydus Wellness take the lead, alongside other prominent companies like Havells India and TCI Express, showcasing positive market momentum and growth potential
The Economic Times
Upvote
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 171,463  •  Jul 21 7:36 PM
HUL, Shree Renuka Sugars among 10 stocks with RSI trending up
HUL, Shree Renuka Sugars among 10 stocks with RSI trending up
Relative Strength Index (RSI) is a valuable technical indicator which gives insights to make informed decisions. It tells about stock's momentum and potential price movements. RSI measures the speed and change of price movements on a scale from 0 to 100, and readings above 70 indicate an overbought condition, while readings below 30 suggest an oversold condition. Analysing RSI trends can help investors gauge a stock's potential for price reversals or continued momentum.
The Economic Times
Upvote
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 171,463  •  Jul 7 8:01 PM
Confusing sugar wars: Defying West, India will go its own sweet way on aspartame
Confusing sugar wars: Defying West, India will go its own sweet way on aspartame
Reports say the World Health Organization is set to classify aspartame as a possible carcinogen. India's FSSAI, which initially banned a natural alternative sugar, stevia in 2011, reversed the order later and gave it its nod. It now says that India may not necessarily follow the West's path on aspartame, as India is currently in a 'powerful' situation.
The Economic Times
Upvote
Comment
Share
Add a comment
Bhaskar Raul-display-image
Reputation: 16  •  Jul 3 5:19 PM

#ZYDUSWELL LOOKING GOOD FOR SWING AND INVESTMENT
ENTRY-CMP
STOPLOSS-1430
TARGET- 1580/1790/2000
Chartbusters - chart - 90925550
Upvote
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 171,463  •  Jun 30 4:28 PM
Zydus Wellness gains after Norges Bank sells stake
Zydus Wellness gains after Norges Bank sells stake
For FY23, the Glucon-D maker's standalone net profit stood at ₹66 crore, a 400 percent jump from the previous fiscal
Moneycontrol
Upvote
Comment
Share
Add a comment
RG finpati-display-image
Reputation: 5,152  •  Jun 30 1:09 PM

Fresh BUY
CMP 1479
Add more at 1200
SL: Closing below 1100
Target 3100
Timeframe: by End of 2026
Chartbusters - chart - 89216895
1 Upvote
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 171,463  •  Jun 29 2:53 AM
HDFC buys additional shares of HDFC Life Insurance; promoters offload stake in Adani Enterprises, Adani Green Energy
HDFC buys additional shares of HDFC Life Insurance; promoters offload stake in Adani Enterprises, Adani Green Energy
Gautam S Adani and Rajesh S Adani, on behalf of SB Adani Family Trust, held 59.13 crore shares or 51.87 percent stake in the company as of March 2023
Moneycontrol
5 Upvotes
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 171,463  •  Jun 26 5:51 AM
Zydus picks 6.5% in Mylab from Adar Poonawala co for ₹106 Cr
Zydus picks 6.5% in Mylab from Adar Poonawala co for ₹106 Cr
Mylab came into limelight during Covid pandemic when it developed and launched indigenous RT-PCR test kits and platform for diagnosing Covid.
The Economic Times
Upvote
Comment
Share
Add a comment
Load More Posts
Hero Img
Create your account on Frontpage
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Stock Sentiments
100% Bullish
0% Bearish
30 live trades of Rs. 2,014,036.4
A
atulthakur306572
 
Reputation: 0 • 
Today 7:08 PM
ZYDUSWELL
50 Qty (S) Trade entered-₹2.5
R
ritubabu
 
Reputation: 0 • 
Today 4:22 PM
ZYDUSWELL
100 Qty (S) Exited-₹20